The endocannabinoid 2-arachidonoylglycerol inhibits endothelial function and repair through cannabinoid 1 (CB1) receptor
- PMID: 33217478
- DOI: 10.1016/j.ijcard.2020.11.027
The endocannabinoid 2-arachidonoylglycerol inhibits endothelial function and repair through cannabinoid 1 (CB1) receptor
Conflict of interest statement
Declaration of Competing Interest The authors report no relationships that could be construed as a conflict of interest.
Comment in
-
Reply to "The endocannabinoid 2-arachidonoylglycerol inhibits endothelial function and repair through cannabinoid 1 (CB1) receptor".Int J Cardiol. 2021 May 1;330:178. doi: 10.1016/j.ijcard.2021.01.033. Epub 2021 Jan 28. Int J Cardiol. 2021. PMID: 33516842 No abstract available.
-
2-arachidonoylglycerol might be a novel therapeutic target in the treatment of cardiovascular disease.Int J Cardiol. 2021 Jun 1;332:162. doi: 10.1016/j.ijcard.2021.03.075. Epub 2021 Mar 31. Int J Cardiol. 2021. PMID: 33811959 No abstract available.
Comment on
-
The endocannabinoid 2-arachidonoylglycerol inhibits endothelial function and repair.Int J Cardiol. 2021 Jan 15;323:243-250. doi: 10.1016/j.ijcard.2020.08.042. Epub 2020 Aug 15. Int J Cardiol. 2021. PMID: 32810540
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
